Search Results

BonAlive™ Granules are sterile medical devices consisting of bioactive glass. Bioactive glass is a bone grafting material that is intended to fill, augment or reconstruct periodontal or bony defects. BonAlive™ Granules are indicated for use in the craniomaxillofacial area including jaws.

BonAlive™ products are sterile medical devices made of S53P4 bioactive glass. Bioactive glasses are characterised by their ability to attach firmly to living tissue. Other properties include being able to bond chemically with surrounding bone in an implantation bed and promote new bone formation in the implanted area. Bone bonding is a physico-chemical process leading to continuity between an implant and bone matrix. It has been shown that tissue bonds to bioactive glass due to formation of a silica-gel layer on the glass. The silica-rich layer acts as a template for a calcium phosphate precipitation, which then bonds the bioactive glass to the surrounding bone. This makes the bioactive glass a unique material for filling defects and replacing damaged bony tissue. The composition of this synthetic, osteoconductive material is, by weight, SiO2 53%, Na2O 23%, CaO 20% and P2O5 4%.

BonAlive™ products are supplied as granules are bone grafting materials intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region. BonAlive™ granules are sterilized in hot dry air. The granules are available as different granule and unit sizes.

The provided text does not contain information about acceptance criteria or a study that proves the device meets specific performance metrics. This 510(k) submission primarily focuses on establishing substantial equivalence to a predicate device based on its composition, intended use, and device description, rather than presenting performance data against defined acceptance criteria.

The document is a 510(k) summary for BonAlive™ Granules, a bone grafting material. It describes the device, its intended use, and its equivalence to a predicate device (NovaBone Perioglas®, NovaBone-C/M®). The FDA letter confirms the substantial equivalence determination.

Therefore, I cannot provide the requested information as it is not present in the given text.

Ask a specific question about this device